通讯作者: 陈昊, chenhao@hust.edu.cn

DOI：10.12201/bmr.202310.00002

Analysis of the Execution of Centralized Drug Procurement Policy Based on Policy Implementation System Model

• 摘要：目的 系统梳理集中采购制度实施中的难点痛点，促进集中带量采购政策的可持续发展，提质增效。方法 结合政策执行系统模型及主题分析法对不同利益相关者的深度访谈结果进行分析。结果与结论研究发现N省药品集中采购政策在政策目标和标准、政策资源、组织间的沟通、执行机构特点、政策系统环境及政策执行者的自身偏好等六方面存在若干问题，并提出了以下建议：一是增加政策的灵活性和适应性，弥补政策缺位和漏洞；二是提高数字资源的质量和兼容性，补充人力资源的缺口，保障物质资源的供应；三是建立有效的省份间信息共享和部门间沟通机制；四是明确执行机构的主体定位，加强对政策执行过程的监管和评估，规范各方的行为和责任；五是关注医药市场的特点和需求，积极探索建立新政策机制以适应环境变化；六是平衡政策执行者的自身偏好，引导各方形成合理的期望和目标，促进政策执行效果的提升。

  关键词： 药品集中采购; 政策执行系统模型; 主题分析法

   

  Abstract: Objective The objective of this study is to systematically identify the challenges and issues in the implementation of the centralized drug procurement policies, promote their sustainable development and enhance their quality and efficiency. Methods This research employs a combination of the policy implementation system model and thematic analysis method to analyze in-depth interview results from various stakeholders. Results and Conclusion Our research found the centralized drug procurement policy in Province N exhibits several issues in six aspects: policy goals and standards, policy resources, communication among organizations, characteristics of executing agencies, policy system environment, and preferences of policy implementers. The following recommendations are proposed: First, enhance policy flexibility and adaptability, address policy gaps and loopholes. Second, improve the quality and compatibility of digital resources, supplement the shortage of human resources, and ensure the supply of material resources. Third, establish effective inter-province information sharing and inter-departmental communication mechanisms. Fourth, clarify the main roles of executing agencies, strengthen policy execution oversight and evaluation, and standardize behaviors and responsibilities of all parties. Fifth, consider the characteristics and demands of the pharmaceutical market, actively explore the establishment of new policy mechanisms to adapt to environmental changes. Sixth, balance the preferences of policy implementers, guide all parties to form reasonable expectations and goals, and promote the improvement of policy execution effectiveness.

  Key words: centralized drug procurement; policy implementation system model; thematic analysis

  提交时间：2023-10-20

  版权声明：作者本人独立拥有该论文的版权，预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。
• html

• 图表

• 孙文俊, 赵子寅, 成哲玉, 李慧宁, 祝贺. 药品集中采购政策对药品价格和使用影响的系统综述. 2023. doi: 10.12201/bmr.202303.00033

  宋佳, 范成鑫, 王婉晨, 艾旭峰, 刘馨璐, 李翠玉, 张玉杰, 李秋莎, 王安琪, 丰志强, 尹文强, 马东平. 利益相关者视角下我国药品集中带量采购政策研究——基于政策工具的文本分析. 2022. doi: 10.12201/bmr.202203.00006

  李洪宇, 孙强. “两票制”政策对山东省药品供应状况影响分析. 2021. doi: 10.12201/bmr.202011.00015

  刘明珠, 路云. 基于间断时间序列的国家药品集中带量采购协议期满品种接续工作实施效果研究——以河北省为例. 2023. doi: 10.12201/bmr.202306.00007

  王彪, 张天天, 唐啸宇, 贾韵, 罗力. 国家组织药品带量采购政策的降价持续性研究. 2023. doi: 10.12201/bmr.202305.00008

  孙言, 朱正, 杨莉. 国家组织药品集中带量采购价格降幅影响因素分析. 2022. doi: 10.12201/bmr.202203.00008

  王彪, 张天天, 唐啸宇, 贾韵, 罗力. 我国集中带量采购中选药品价格的差异及区域分布研究. 2023. doi: 10.12201/bmr.202306.00008

  韩朦, 王诗嘉, 胡皓钰, 赵艳蛟, 陈永法. 中成药集中带量采购分组规则对比研究. 2023. doi: 10.12201/bmr.202312.00008

  李钊, 赵珂, 周绿林, 陈盛. 国家集采常态化视域下药品集团采购模式对比及发展对策研究. 2021. doi: 10.12201/bmr.202109.00037

  李新宇, 邵蓉, 白铭钰, 李大双, 颜建周. 我国儿童药保障政策文本量化分析——基于政策工具、政策目标的二维框架. 2022. doi: 10.12201/bmr.202209.00016

• 序号	提交日期	编号	操作
  1	2023-06-29	bmr.202310.00002V1	下载

• 公开评论  匿名评论  仅发给作者 提交评论